Gambia says child deaths linked to Indian-made cough syrup have risen to 70

Syrup was found to be made by New Delhi-based Maiden Pharmaceuticals Ltd


Reuters October 15, 2022

BANJUL:

Gambia's government on Friday said the number of child deaths from acute kidney injury, thought to be linked to Indian-made cough syrups, has risen to 70 from a previous toll of 69.

President Adama Barrow gave the update at an emergency cabinet meeting which he convened on Thursday to discuss the crisis, according to a presidency statement.

Read more: WHO issues alert against Indian-made syrups after 66 children die in Gambia

The syrups were found to be made by New Delhi-based Maiden Pharmaceuticals Ltd, which has since had one of its factories shut down in northern India as health authorities there investigate.

Gambia is also investigating the deaths and this week set up a new commission of inquiry to deal with them, the statement said.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ